Positive allosteric modulation of the adenosine A2a receptor attenuates inflammation

作者: Ajith A Welihinda , Edward P Amento

DOI: 10.1186/S12950-014-0037-0

关键词: Adenosine A3 receptorAdenosine A1 receptorPurinergic signallingAdenosine A2B receptorAdenosine A2A receptorAdenosine receptorAdenosineMedicinePharmacologyCGS-21680

摘要: Adenosine is produced at high levels inflamed sites as a by-product of cellular activation and breakdown. mediates its anti-inflammatory activity primarily through the adenosine A2a receptor (A2aR), member G-protein coupled receptors. A2aR agonists have demonstrated efficacy, however, their therapeutic utility hindered by lack subtype selectivity upon systemic exposure. We sought to harness effects enhancing responsiveness endogenously allosteric modulation. identified family positive modulators (PAMs) A2aR. Using one this PAM family, AEA061, we demonstrate that A2aRs are amenable enhancement such produces increased signaling diminished inflammation in vivo. was evaluated using cell-based cAMP assay. Binding affinity determined [3H]CGS 21680. A2aR-mediated quantified [35S]GTP-γS. The effect AEA061 on cytokine production primary monocytes splenocytes. LPS-induced mouse model inflammation. had no detectable intrinsic agonist towards either rat or human A2aRs. enhanced efficacy 11.5 2.8 fold respectively. also maximal response 4.2 2.1 for potentiated agonist-mediated Gα 3.7 fold. Additionally, both well Bmax 1.8 3 Consistent with role A2aR, inhibited TNF-α, MIP-1α, MIP-1β, MIP-2, IL-1α, KC RANTES LPS-stimulated macrophages and/or Moreover, reduced circulating plasma TNF-α MCP-1 IL-10 endotoxemic intact, but not deficient, mice. increases adenosine, thereby increasing potency which translates responsiveness. Since negatively regulates inflammation, PAMs offer novel means modulating inflammatory processes.

参考文章(34)
Ribeiro, J. A. (Ribeiro, J. Alexandre), Adenosine receptors in the nervous system Taylor & Francis. ,(1989)
Constance N. Wilson, Ahmed Nadeem, Domenico Spina, Rachel Brown, Clive P. Page, S. Jamal Mustafa, Adenosine Receptors and Asthma Adenosine Receptors in Health and Disease. ,vol. 193, pp. 329- 362 ,(2009) , 10.1007/978-3-540-89615-9_11
Mark E. Olah, Identification of A2aAdenosine Receptor Domains Involved in Selective Coupling to GS Journal of Biological Chemistry. ,vol. 272, pp. 337- 344 ,(1997) , 10.1074/JBC.272.1.337
R A Brown, D Spina, C P Page, Adenosine receptors and asthma. British Journal of Pharmacology. ,vol. 153, ,(2009) , 10.1038/BJP.2008.22
K.-N. Klotz, J. Hessling, J. Hegler, C. Owman, B. Kull, B. B. Fredholm, M. J. Lohse, Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells Naunyn-Schmiedeberg's Archives of Pharmacology. ,vol. 357, pp. 1- 9 ,(1997) , 10.1007/PL00005131
Katie Leach, Patrick M. Sexton, Arthur Christopoulos, Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. Trends in Pharmacological Sciences. ,vol. 28, pp. 382- 389 ,(2007) , 10.1016/J.TIPS.2007.06.004
Wieslaw Kazmierski, Larry Boone, Wendell Lawrence, Chris Watson, Terry Kenakin, CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection Current Drug Targets - Infectious Disorders. ,vol. 2, pp. 265- 278 ,(2002) , 10.2174/1568005023342489
György Haskó, Bruce N Cronstein, None, Adenosine: an endogenous regulator of innate immunity Trends in Immunology. ,vol. 25, pp. 33- 39 ,(2004) , 10.1016/J.IT.2003.11.003
Kenneth A. Jacobson, Zhan-Guo Gao, Adenosine receptors as therapeutic targets Nature Reviews Drug Discovery. ,vol. 5, pp. 247- 264 ,(2006) , 10.1038/NRD1983